Programme for BASL MASLD SIG meeting 5th September 2025
Venue details for BASL MASLD SIG meeting 5th September 2025
Really nice to be hosting the BASL #MASLD SIG at Jesus College Oxford on 5th September
📢Attendance is FREE and registration is EASY. There are still a few spaces left.
🔗(tinyurl.com/4j8esadr)
Really great mix of speakers. AM = Basic/Translational science; PM = Clinical updates
Mechanism underpinning muscle pathology in MASLD and impact of exercise on liver histology
🔗 shorturl.at/aFO1Q
Graphic showing assessment methods for various domains of muscle quality and function in patients with MASLD including insulin resistance, myosteatosis, sarcopenia, and frailty.
📢Great to write this review for Hep Comms with Matt Armstrong & @jonathanstinemd.bsky.social
💪We've covered everything you need to know about #Muscle & #MASLD
- Insulin resistance
- Sarcopenia
- Myosteatosis
- Impact of weight loss drugs
- Benefits of exercise
🔗 shorturl.at/aFO1Q
#LiverSky
It was an absolute delight to contribute to this high-impact work with @tom-marjot.bsky.social and @mattarmstrong95.bsky.social in which we review all things #MASLD and #Muscle!
If you're looking for holiday weekend reading, look no further:
journals.lww.com/hepcomm/page...
@ebtapper.bsky.social
BS @easlnews.bsky.social Congress
Wed 7🗓️Whole-day seminar plus a wet lab on spatial biology (NEW THIS YEAR‼️)
Thu 8🗓️State of the Art by Lars Zender
Fri 9🗓️MTE sessions on MASLD & MetALD
Sat 10🗓️Microbiome session co-chaired by our own @debbieshawcross.bsky.social
& more!🔗https://tinyurl.com/4ky9r3x9
In these unprecedented dark times for American life science and medical research (no less well beyond biomedicine), my coping mechanism is to laser focus on the unremitting and remarkable daily advances, and the fervent hope these will not be slowed or interrupted.
Original paper in @nature.com :
🔗https://shorturl.at/jcWYE
👏 @gjpattij.bsky.social
BBJ article in Journal of Hepatology:
🔗https://shorturl.at/4E2qT
@jhepatology.bsky.social
@easlnews.bsky.social
Highlights from latest article in Breakthroughs Beyond the Journal in Journal of Hepatology. It showcases work published in Nature.
Breakthroughs Beyond the Journal @jhepatology.bsky.social
🚨The liver is central to fructose-associated cancer
▶️Tumors cannot use fructose directly
▶️Liver converts to specific lipids (LPC)
▶️LPCs integrate into new cancer membranes
Can this explain link between MASLD & extra-hepatic cancer?
There has been a recent influx to #gisky and #liversky
To sustain this, you need to be active. If you were a lurker, no we need your pearls, papers, and pets. Post. Use the hashtags. Build.
Young Investigator Poster Tour @easlnews.bsky.social #SLDSummit
Huge attendance and interest! 👏🏼
@tom-marjot.bsky.social @madsisraelsen.bsky.social
2025 is the perfect year to take your career to the next level🚀
There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force.
Apply by 20 January: easl.eu/leadership25
#LiverSky
By @adhanda.bsky.social & @tom-marjot.bsky.social
#Sharedit link: rdcu.be/d5rwu
Thoughtful piece from Marjot & Dhanda (@adhanda.bsky.social) in @natrevgastrohep.bsky.social: Alcohol-free drinks show promise for motivated individuals to reduce alcohol consumption but may pose relapse risks in others. Balance is key for clinical guidance. 🧪
www.nature.com/articles/s41...
Do read my comment piece with @tom-marjot.bsky.social on NoLo alcohol 👇🏾
🔗Original paper from Xie et al.👏: shorturl.at/T6xkg
🔗Breakthroughs Beyond the Journal: shorturl.at/8lae8
New evidence of cross-disease communication between heart and liver
1: In 2025, look out for a new section in Journal of Hepatology: "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research. #LiverSky
2: My comment on work from Cell Metabolism showing that MI drives #MASH. The interaction between these two conditions works BOTH ways👇
Good to see you here @easlnews.bsky.social !
Hello, #MedSky community! We’re excited to begin our Bluesky journey.
Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
#LiverSky Come join in T-minus 26 mins for EASL Studio! #Sarcopenia #Exercise #Nutrition #Frailty #MASLD #LiverTransplant
Tumor seeding is a dreaded complication of biopsy for HCC. But how common is it?
A systematic review in @amcollegegastro.bsky.social #AmJGastro reports a rate of tumor seeding of 0.62% with even lower rates in recent years
#LiverSky
Link: journals.lww.com/ajg/abstract...
#LiverSky
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
📌
1/3 What happens when science and every day clinical practice comes together?
A 🧵
You get a packed room with not even a place to stand 👇🏼
Why?
I firmly believe that we need to bridge the gap between research and clinical application in our scientific meetings.
#TLM24
A figure from a scientific paper showing a single Flow Cytometry (FACS) panel. It looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.
A figure from a scientific paper showing four Flow Cytometry (FACS) panels. Each looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.
This artwork was published in the Journal of Immunology, published by @immunologyaai.bsky.social - which appears not to give a fork.
pubpeer.com/publications...
The Chinese government also did not see any problem.
www.science.org/content/arti...
#ThisImageIsFine
